Serveur d'exploration MERS - Exploration (Accueil)

Index « Keywords » - entrée « Drug Design »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Delivery Systems (trends) < Drug Design < Drug Development  Facettes :

List of bibliographic references indexed by Drug Design

Number of relevant bibliographic references: 31.
[20-40] [0 - 20][0 - 31]
Ident.Authors (with country if any)Title
002B25 (2007) Margaret C. Hsu [États-Unis] ; Jinhwa Lee ; Yoshito KishiSynthetic 3-O-methylmannose-containing polysaccharides (sMMPs): design and synthesis.
002B29 (2007) Ravi Hegde [Israël] ; Gadi Borkow ; Alexander Berchanski ; Aviva LapidotStructure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.
002B74 (2007) Jean-Yves Springael [Belgique] ; Eneko Urizar ; Sabine Costagliola ; Gilbert Vassart ; Marc ParmentierAllosteric properties of G protein-coupled receptor oligomers.
002E91 (2005) Joel N H. Stern [États-Unis] ; Zsolt Illés ; Jayagopala Reddy ; Derin B. Keskin ; Masha Fridkis-Hareli ; Vijay K. Kuchroo ; Jack L. StromingerPeptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitis.
003311 (2002) Tami L. Raguse [États-Unis] ; Emilie A. Porter ; Bernard Weisblum ; Samuel H. GellmanStructure-activity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency.
003444 (2001) K H Mayo [États-Unis] ; D W Van Der Schaft ; A W GriffioenDesigned beta-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cells.
003793 (1999) S M Gryaznov [États-Unis]Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents.
003A10 (1998) G J Hanson [États-Unis]DR (MHC class II) ligands: an approach to rheumatoid arthritis therapeutics.
003A89 (1998) Makoto Koizumi [Japon] ; Rika Koga [Japon] ; Hitoshi Hotoda [Japon] ; Toshinori Ohmine [Japon] ; Hidehiko Furukawa [Japon] ; Toshinori Agatsuma [Japon] ; Takashi Nishigaki [Japon] ; Koji Abe [Japon] ; Toshiyuki Kosaka [Japon] ; Shinya Tsutsumi [Japon] ; Junko Sone [Japon] ; Masakatsu Kaneko [Japon] ; Satoshi Kimura [Japon] ; Kaoru Shimada [Japon]Biologically active oligodeoxyribonucleotides. Part 11: The least phosphate-modification of quadruplex-forming hexadeoxyribonucleotide TGGGAG, bearing 3′- and 5′-end-modification, with anti-HIV-1 activity
003E07 (1996) S M Rink [États-Unis] ; K J Yarema ; M S Solomon ; L A Paige ; B M Tadayoni-Rebek ; J M Essigmann ; R G CroySynthesis and biological activity of DNA damaging agents that form decoy binding sites for the estrogen receptor.
005424 (????) V. Theodorou [Grèce] ; V. Tsikaris ; M. Sakarellos-Daitsiotis ; V. Avramopoulou ; K. Kostelidou ; S J Tzartos ; C. SakarellosDesign, synthesis, and conformational study of biologically active photolabeled analogues of the main immunogenic region of the acetylcholine receptor.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Drug Design" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Drug Design" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Drug Design
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021